Medicines Co. (MDCO) Misses Q4 EPS by 23c

Medicines Co. (NASDAQ: MDCO) reported Q4 EPS of ($1.77), $0.23 worse than the analyst estimate of ($1.54). Revenue for the quarter came in at $25.2 million versus the consensus estimate of $26.91 million.

For earnings history and earnings-related data on Medicines Co. (MDCO) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• SentinelOne, Inc. (S) Tops Q2 EPS by 1c; offers guidance
• Titan Machinery (TITN) Misses Q2 EPS by 5c ; Offers Guidance